誉衡药业
(002437)
| 流通市值：43.60亿 | | | 总市值：45.18亿 |
| 流通股本：21.91亿 | | | 总股本：22.71亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 711,275,270.6 | 936,716,329.91 | 977,922,734.73 | 1,246,281,403.7 |
| 应收票据及应收账款 | 205,969,515.14 | 186,717,110.39 | 210,086,447.04 | 203,375,325.64 |
| 其中：应收票据 | 729,323.06 | - | 199,000 | 602,622.8 |
| 应收账款 | 205,240,192.08 | 186,717,110.39 | 209,887,447.04 | 202,772,702.84 |
| 应收款项融资 | 1,699,807.4 | 2,978,399.73 | 3,929,918 | 4,908,366.43 |
| 预付款项 | 10,245,945.29 | 15,379,136.21 | 15,435,614.73 | 14,920,530.86 |
| 其他应收款合计 | 26,651,941.36 | 153,779,850.69 | 37,480,598.07 | 38,153,208.43 |
| 存货 | 190,666,605.53 | 206,401,201.76 | 204,526,795.3 | 216,142,605.33 |
| 其他流动资产 | 7,940,575.63 | 7,615,510.65 | 11,257,852.17 | 9,555,370.2 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,154,449,660.95 | 1,529,637,539.34 | 1,460,639,960.04 | 1,738,338,700.12 |
| 非流动资产: | | | | |
| 长期股权投资 | 68,544,332.6 | 67,661,231.1 | 236,746,375.99 | 261,117,119.57 |
| 其他权益工具投资 | 79,974,592.14 | 78,970,365.7 | 5,081,465.7 | 5,081,465.7 |
| 其他非流动金融资产 | 149,710,131.91 | 152,006,631.53 | 159,890,960.15 | 167,367,723.41 |
| 投资性房地产 | 32,473,685.32 | 32,771,880.02 | 33,070,074.74 | 33,272,086.39 |
| 固定资产 | 1,055,568,594.1 | 1,078,397,986.14 | 1,095,084,374.61 | 1,094,784,656.44 |
| 在建工程 | 3,045,406.14 | 1,091,852.65 | 848,036.55 | 12,341,140.95 |
| 无形资产 | 191,300,356.59 | 198,699,858 | 206,184,001.44 | 213,685,678.72 |
| 开发支出 | 8,230,847.78 | 6,763,269.8 | 6,086,579.05 | 5,373,707.19 |
| 商誉 | 369,032,276.3 | 369,032,276.3 | 369,032,276.3 | 369,032,276.3 |
| 长期待摊费用 | - | 943,396.05 | 2,358,490.35 | 3,773,584.65 |
| 递延所得税资产 | 21,009,217.65 | 30,579,073.18 | 31,162,127.42 | 31,601,968.69 |
| 其他非流动资产 | 19,111,003.71 | 12,776,118.53 | 11,429,864.13 | 12,631,612.97 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,998,000,444.24 | 2,029,693,939 | 2,156,974,626.43 | 2,210,063,020.98 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,152,450,105.19 | 3,559,331,478.34 | 3,617,614,586.47 | 3,948,401,721.1 |
| 流动负债: | | | | |
| 短期借款 | 675,689,728.35 | 800,900,398.08 | 1,001,124,920.64 | 1,372,828,749.33 |
| 应付票据及应付账款 | 69,876,119.26 | 83,707,642.87 | 80,863,293.83 | 69,797,410.12 |
| 应付账款 | 69,876,119.26 | 83,707,642.87 | 80,863,293.83 | 69,797,410.12 |
| 合同负债 | 50,027,377.56 | 38,814,602.59 | 44,154,381.59 | 55,393,343.1 |
| 应付职工薪酬 | 84,475,337.98 | 92,401,273.69 | 89,374,372.27 | 80,626,117.46 |
| 应交税费 | 37,253,543.8 | 37,432,717.77 | 42,446,039.5 | 35,247,365.16 |
| 其他应付款合计 | 488,622,759.85 | 611,757,771.94 | 595,167,010.2 | 580,575,608.44 |
| 应付股利 | 1,226,505.38 | 1,226,505.38 | 1,226,505.38 | 1,226,505.38 |
| 其他流动负债 | 6,283,406.22 | 4,720,335.35 | 5,783,321.31 | 7,386,708.11 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,412,228,273.02 | 1,669,734,742.29 | 1,858,913,339.34 | 2,201,855,301.72 |
| 非流动负债: | | | | |
| 长期应付款 | - | - | - | 27,624.26 |
| 递延收益 | 17,873,938.63 | 19,218,065.16 | 20,189,789.34 | 20,611,513.52 |
| 递延所得税负债 | 12,117,073.91 | 12,281,086.59 | 12,469,336.08 | 12,659,654.99 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 29,991,012.54 | 31,499,151.75 | 32,659,125.42 | 33,298,792.77 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,442,219,285.56 | 1,701,233,894.04 | 1,891,572,464.76 | 2,235,154,094.49 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,198,122,950 | 2,198,122,950 | 2,198,122,950 | 2,198,122,950 |
| 资本公积 | 380,472,624.78 | 404,708,623.37 | 471,152,387.03 | 471,126,143.98 |
| 其他综合收益 | -7,690,401.28 | -7,184,073.19 | -6,905,270.45 | -9,259,537.67 |
| 专项储备 | 4,375,197.77 | 4,375,197.77 | 4,375,197.77 | 4,375,197.77 |
| 未分配利润 | -913,507,023.79 | -810,217,660.31 | -1,005,592,182.91 | -1,013,782,611.42 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,661,773,347.48 | 1,789,805,037.64 | 1,661,153,081.44 | 1,650,582,142.66 |
| 少数股东权益 | 48,457,472.15 | 68,292,546.66 | 64,889,040.27 | 62,665,483.95 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,710,230,819.63 | 1,858,097,584.3 | 1,726,042,121.71 | 1,713,247,626.61 |
| 负债和股东权益合计 | 3,152,450,105.19 | 3,559,331,478.34 | 3,617,614,586.47 | 3,948,401,721.1 |
| 公告日期 | 2024-04-20 | 2023-10-27 | 2023-07-29 | 2023-04-24 |
| 审计意见(境内) | 标准无保留意见 | | | |